LEO Pharma owners say market conditions unsuitable for IPO, casting doubt on 2026 listing
Reuters (via 104.9 The Wolf) · · AI-summarised by FinFlash
LEO Pharma CEO Christophe Bourdon said the Danish drugmaker's owners do not consider current market conditions right for a listing, casting doubt on plans to float before end-2026. He still called an IPO a natural and viable option, depending on performance and investor appetite. The LEO Foundation owns 80% and Nordic Capital the rest after investing 450 million euros in 2021. Earlier reports had flagged a Copenhagen listing.
So What?
Another sign of a cooling European IPO window as AI-driven volatility hits markets; delays supply of new listings on Nasdaq Copenhagen.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.